Company / Current Liabilities per Share
Kymera Therapeutics, Inc. Current Liabilities per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$1.28
FY2025
5-year range
$1.22 / $2.08
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
#99 of 210
Health Care
What the data says
At $1.28, Kymera Therapeutics, Inc.'s current liabilities per share ranks #112 of 210 in the Health Care sector. Current Liabilities per Share has fluctuated over the past 7 years, ranging from $1.22 in FY2024 to $57.33 in FY2020.
Based on SEC 10-K filings.
1.28 in FY2025 with a 5-year CAGR of -53.2%.
Improved from $1.79 to $1.28 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -2.5%
- 5-Year CAGR
- -53.2%
- 10-Year CAGR
- -
Sector benchmark
-91.9% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 5.2% year-over-year.
- Ranks #99 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2020.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.27 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.28 | +5.2% |
| FY2024 | $1.22 | -31.7% |
| FY2023 | $1.79 | +29.0% |
| FY2022 | $1.38 | -33.5% |
| FY2021 | $2.08 | -96.4% |
| FY2020 | $57.33 | +181.7% |
| FY2019 | $20.35 | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 30, 2026